$22.74
-5.72-20.10%
At Close: -
$22.70
-0.04-0.18%
After Hours: 7:26 PM EDT
15 minutes delayed
Pacira BioSciences
PCRXNASDAQ
Pacira BioSciences (PCRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Pacira BioSciences (NASDAQ:PCRX) Stock Quotes, Forecast and News Summary
Pacira BioSciences Stock (NASDAQ: PCRX) stock price, news, charts, stock research, profile.
| Open | $28.25 |
| Close | $22.74 |
| Volume / Avg. | 9.13M / 754.15K |
| Day Range | 20.52 - 28.63 |
| 52 Wk Range | 25.33 - 40.45 |
| Market Cap | $1.06B |
| P/E Ratio | 18.85 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 26 |
| Short Interest | 19.83% |
| Days to Cover | 10.24 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Pacira BioSciences Inc
Sector
Health Care
Industry
Pharmaceuticals
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pacira BioSciences (PCRX) stock?
You can purchase shares of Pacira BioSciences (NASDAQ:PCRX) through any online brokerage.
Who are Pacira BioSciences (PCRX) competitors?
Other companies in Pacira BioSciences’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Rapport Therapeutics (NASDAQ:RAPP), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
What is the target price for Pacira BioSciences (PCRX) stock?
There is no analysis for Pacira BioSciences.
What is the forecast for Pacira BioSciences (PCRX) stock?
Pacira BioSciences has a consensus price target of $56.87.
Current stock price for Pacira BioSciences (PCRX)?
The stock price for Pacira BioSciences (NASDAQ: PCRX) is $22.7 last updated July 2, 2024 at 7:26 PM EDT.
Does Pacira BioSciences (PCRX) pay a dividend?
There are no upcoming dividends for Pacira BioSciences.
When is Pacira BioSciences (NASDAQ:PCRX) reporting earnings?
Pacira BioSciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
Is Pacira BioSciences (PCRX) going to split?
There is no upcoming split for Pacira BioSciences.
What sector and industry does Pacira BioSciences (PCRX) operate in?
Pacira BioSciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.